S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 11.88 CNY -5.64% Market Closed
Market Cap: 7.8B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Gross Margin
Shandong Sinobioway Biomedicine Co Ltd

78.9%
Current
78%
Average
23.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.9%
=
Gross Profit
340.3m
/
Revenue
431.4m

Gross Margin Across Competitors

Country CN
Market Cap 7.8B CNY
Gross Margin
79%
Country ZA
Market Cap 61.5B Zac
Gross Margin
50%
Country DE
Market Cap 38B EUR
Gross Margin
25%
Country IN
Market Cap 1.5T INR
Gross Margin
54%
Country CN
Market Cap 117.6B CNY
Gross Margin
31%
Country ZA
Market Cap 12.3B Zac
Gross Margin
22%
Country JP
Market Cap 1.2T JPY
Gross Margin
27%
Country IN
Market Cap 641.2B INR
Gross Margin
38%
Country JP
Market Cap 6.9B EUR
Gross Margin
27%
Country FR
Market Cap 5.6B EUR
Gross Margin
20%
Country JP
Market Cap 752.5B JPY
Gross Margin
46%
No Stocks Found

Shandong Sinobioway Biomedicine Co Ltd
Glance View

Market Cap
7.8B CNY
Industry
Chemicals

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 653 full-time employees. The company went IPO on 2011-05-20. The firm's main products include encyclopedia, anferon, triethyl orthoformate, trimethyl orthofomate, trimethyl orthoacetate and related secondary products, among others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
3.08 CNY
Overvaluation 74%
Intrinsic Value
Price
S

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.9%
=
Gross Profit
340.3m
/
Revenue
431.4m
What is the Gross Margin of Shandong Sinobioway Biomedicine Co Ltd?

Based on Shandong Sinobioway Biomedicine Co Ltd's most recent financial statements, the company has Gross Margin of 78.9%.